The Valley Desk

ArticleEuropean journal of nuclear medicine and molecular imagingPublished

First-in-human study of dosimetry, safety and efficacy for [177Lu]Lu-P15-073: a novel bisphosphonate-based radioligand therapy (RLT) agent for bone metastases

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
European journal of nuclear medicine and molecular imaging
Published
Subject terms
Humans; Bone Neoplasms; Lutetium; Radioisotopes; Diphosphonates; Radiopharmaceuticals; Treatment Outcome; Radiometry; Safety; Tissue Distribution; Adult; Aged
PubMed ID
39419848
Added to directory
Source checked

Report a correction or request removal